HIV Preexposure Prophylaxis Awareness and Referral to Providers Among Hispanic/Latino Persons — United States, 2019

Rao, Shubha; Mulatu, Mesfin S.; Xia, Mingjing; Wang, Guoshen; Song, Wei; Essuon, Aba; Patel, Deesha A.; Eke, Adanze; German, Emilio J.; Mshsa,

doi:10.15585/mmwr.mm7040a1

Cited by 13 publications

(18 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Individual, social, and structural barriers, including lack of health insurance, PrEP-related and HIV-related stigma, and lower HIV risk perception contribute to lower PrEP awareness. 26,27 Routinizing PrEP education and referrals and implementing culturally and linguistically relevant strategies might improve PrEP awareness and optimal and equitable use of PrEP among MSM communities. 26,28 Interventions have shown to be effective in increasing PrEP awareness among MSM, including social media campaigns, social marketing strategies, community education materials, peer networks, support groups, and culturally and linguistically competent staffing of services.…”

Section: Discussionmentioning

confidence: 99%

“…26,27 Routinizing PrEP education and referrals and implementing culturally and linguistically relevant strategies might improve PrEP awareness and optimal and equitable use of PrEP among MSM communities. 26,28 Interventions have shown to be effective in increasing PrEP awareness among MSM, including social media campaigns, social marketing strategies, community education materials, peer networks, support groups, and culturally and linguistically competent staffing of services. [26][27][28] Among HIV-negative MSM eligible for a PrEP referral, 47.1% were referred to a PrEP provider.…”

Section: Discussionmentioning

confidence: 99%

“…26,28 Interventions have shown to be effective in increasing PrEP awareness among MSM, including social media campaigns, social marketing strategies, community education materials, peer networks, support groups, and culturally and linguistically competent staffing of services. [26][27][28] Among HIV-negative MSM eligible for a PrEP referral, 47.1% were referred to a PrEP provider. Although there were some differences by age and racial/ethnic groups, in general, the percentage of persons eligible for a PrEP referral remained between 40% and 50%.…”

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 3 more Smart Citations

HIV Positivity, Linkage to Medical Care, Interview for Partner Services, and Pre-Exposure Prophylaxis Awareness and Referral Among Men Who Have Sex With Men Tested in Non-healthcare Settings in the United States, 2019

Wang

Song

Rao

et al. 2023

JAIDS Journal of Acquired Immune Deficiency Syndromes

Self Cite

View full text Add to dashboard Cite

Objectives:Gay, bisexual, and other men who have sex with men (MSM) are disproportionately affected by HIV. This study reports data on HIV testing program outcomes among MSM tested for HIV in non-healthcare settings in the United States.Methods:We analyzed Centers for Disease Control and Prevention's National HIV Prevention Program Monitoring and Evaluation data collected in 2019. Descriptive and multivariate robust Poisson regression analyses were conducted to summarize the patterns of HIV testing program outcomes [ie, positivity, linkage to HIV medical care within 30 days of diagnosis, interview for partner services (PS), and pre-exposure prophylaxis (PrEP) awareness and referral] by demographic characteristics, HIV prevalence, and testing site type.Results:A total of 123,251 HIV tests were conducted among MSM; of these, 1773 (1.4%) were newly diagnosed with HIV. Among MSM newly diagnosed with HIV, 75% were linked to HIV medical care and 80% were interviewed for PS. Among MSM who tested HIV-negative, 63% were aware of PrEP and 47% of those who were eligible for PrEP were referred to PrEP providers. Referral or linkage to services varied by demographic characteristics or other factors.Conclusions:Linkage to HIV medical care and interview for PS among MSM newly diagnosed with HIV in non-healthcare settings were below national or funding program targets. Most MSM with risk factors for HIV infection were not referred to PrEP providers. Expanded efforts to address barriers to equitable access to services may help improve HIV-related outcomes among MSM and contribute to ending the HIV epidemic in the United States.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

HIV Positivity, Linkage to Medical Care, Interview for Partner Services, and Pre-Exposure Prophylaxis Awareness and Referral Among Men Who Have Sex With Men Tested in Non-healthcare Settings in the United States, 2019

Wang

Song

Rao

et al. 2023

JAIDS Journal of Acquired Immune Deficiency Syndromes

Self Cite

View full text Add to dashboard Cite

show abstract

“…Despite all efforts made, to achieve an effective cure against HIV-1 infection is still an elusive goal. The only one effective preventive treatment to date is the pre-exposure prophylaxis (PreP) [ 5 ]. However, PreP is not available to a widespread risky population due to the limited availability and excessive cost.…”

Section: Introductionmentioning

confidence: 99%

Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants

et al. 2022

View full text Add to dashboard Cite

Background The absence of an effective treatment and vaccine in HIV-1 pandemic place preventive strategies such as safety and effective microbicide development as a central therapeutic approach to control HIV-1 pandemic nowadays. Results Studies of cytotoxicity, immune population status, inflammation or tissue damage and mainly prophylactic inhibition of HIV-1 infection in vaginal human explants demonstrate the biosafety and effectivity of G2-S16 dendrimer. Human explants treated with G2-S16 dendrimer or treated and HIV-1 infected do not presented signs of irritation, inflammation, immune activation or T cell populations deregulation. Conclusions Herein we conclude that G2-S16 dendrimer has demonstrated sufficient efficacy, biosafety, effectivity and behavior in the closest to the real-life condition model represented by the human healthy donor vaginal tissue explants, to raise G2-S16 dendrimer as a promising candidate to clinical trials to develop an effective microbicide against HIV-1 infection. Graphical Abstract

show abstract

PrEP and Behavioral Health Treatment Referral Among HIV Test Counselors in Miami-Dade County: A Rapid Qualitative Study Using the Consolidated Framework for Implementation Research

Harkness,

Morales,

Atuluru

et al. 2023

AIDS Behav

View full text Add to dashboard Cite

HIV Preexposure Prophylaxis Awareness and Referral to Providers Among Hispanic/Latino Persons — United States, 2019

Cited by 13 publications

References 7 publications

HIV Positivity, Linkage to Medical Care, Interview for Partner Services, and Pre-Exposure Prophylaxis Awareness and Referral Among Men Who Have Sex With Men Tested in Non-healthcare Settings in the United States, 2019

HIV Positivity, Linkage to Medical Care, Interview for Partner Services, and Pre-Exposure Prophylaxis Awareness and Referral Among Men Who Have Sex With Men Tested in Non-healthcare Settings in the United States, 2019

Safety and efficacy of G2-S16 dendrimer as microbicide in healthy human vaginal tissue explants

PrEP and Behavioral Health Treatment Referral Among HIV Test Counselors in Miami-Dade County: A Rapid Qualitative Study Using the Consolidated Framework for Implementation Research

Contact Info

Product

Resources

About